New quadruple therapy aims to control liver cancer in diabetic patients
Disease control
Not yet recruiting
This study tests a combination of four drugs (epalrestat, HAIC chemotherapy, donafenib, and tislelizumab) as a first treatment for people with advanced liver cancer that cannot be removed by surgery and who also have diabetes. The goal is to see if this approach can keep the canc…
Phase: PHASE2 • Sponsor: Haibo Shao • Aim: Disease control
Last updated May 14, 2026 12:04 UTC